ChinaXiv:新冠时期,为什么精神分裂症发病率也上升了?

2020-03-03 Walter 转化医学网

近日,重庆陆军军医大学和徐州东方人民医院的专家联合在中科院科技论文预发布平台ChinaRxiv上发表重要结果,发现新冠肺炎爆发以来,精神分裂症发病率显著上升,发病人群老龄化,提示在做好防疫抗疫工作的同时,也要注意广大民众的心理防线建设。

导读:距武汉封城已经过去整整40天,经过顽强的努力抗争,我们终于扼住了疫情的咽喉,迎来了抗疫攻坚战的关键时期。但在这难捱的一个多月里,我们都被新冠肺炎的信息狂潮裹挟着前进,被迫面临离别,被迫坚强。面对病疫,也是心疫,你还好吗?

近日,重庆陆军军医大学和徐州东方人民医院的专家联合在中科院科技论文预发布平台ChinaRxiv上发表重要结果,发现新冠肺炎爆发以来,精神分裂症发病率显著上升,发病人群老龄化,提示在做好防疫抗疫工作的同时,也要注意广大民众的心理防线建设。



前期研究表明,大型流行病会对健康人群的心理造成众多负面影响,包括焦虑、抑郁和失眠;2009年H1N1爆发时,人们对未知信息的不断接受、自我评价和重复性行为导致了不同程度的焦虑症状;2003年非典时期,自杀率显著上升。尽管此次新冠病毒的杀伤力并不强,但随着疫情在全球的蔓延,偶尔物资短缺造成的混乱以及交通管制,或多或少已经侵害到了人们的心理健康
研究者们对2020年1月徐州东方人民医院(精神防治院)的13783例患者就诊记录进行回溯性研究,其中包含1210名初诊患者(8.75%)和12573名复诊患者(91.22%)。研究者发现,新冠肺炎确认爆发初期(一月底)精神分裂症患者数量较一月初上升25%,较2017-2019年同期平均上升10%,并排除了春节假期和季节引起发病率升高的可能性。


精神分类初诊患者较同期的相对变化

研究者进一步发现,一月底病人数量与新冠肺炎在全球的爆发数呈现一定的相关性。另外,初诊患者的中位数年龄从2017-2019的39岁,提高到今年的50岁,说明新冠肺炎造成的恐慌波及一大群体,并着重影响老年人的心理健康


新冠疫情使精神分裂症风险老龄化

本研究仅选取了一个城市、一种疾病,不具有广泛代表性,但却是疫情下公众心理健康的缩影和危险预警信号。在徐州,八百万人口、仅有23例新冠肺炎确诊病例的低风险区,就观察到了如此明显的精神疾病发病率增加;那么一千五百万人口的爆发中心武汉、十四亿人口的全中国、乃至七十亿人口的全世界,又有多少人正被洪水猛兽一般的病毒和与之相伴的负面情绪所击垮呢?
本研究从精神分裂症切入,强调了新冠肺炎对民众心理健康产生的潜在危害,而年纪较大的老人更是承受病毒和精神压力的双重风险。在时间、空间和信息的多维打击下,调节自身心态、振作抗疫信心,并对家中老人的心理健康状况多加关心,是后方群众巩固防疫阵地的重中之重!

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1823613, encodeId=a56b182361365, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Thu Jan 14 16:17:00 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008137, encodeId=8dbb200813e86, content=<a href='/topic/show?id=f244465139' target=_blank style='color:#2F92EE;'>#CHINA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4651, encryptionId=f244465139, topicName=CHINA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Mon Jul 13 09:17:00 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404123, encodeId=7ae8140412346, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Mar 05 00:17:00 CST 2020, time=2020-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027316, encodeId=ac10102e316ac, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Mar 03 12:17:00 CST 2020, time=2020-03-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1823613, encodeId=a56b182361365, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Thu Jan 14 16:17:00 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008137, encodeId=8dbb200813e86, content=<a href='/topic/show?id=f244465139' target=_blank style='color:#2F92EE;'>#CHINA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4651, encryptionId=f244465139, topicName=CHINA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Mon Jul 13 09:17:00 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404123, encodeId=7ae8140412346, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Mar 05 00:17:00 CST 2020, time=2020-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027316, encodeId=ac10102e316ac, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Mar 03 12:17:00 CST 2020, time=2020-03-03, status=1, ipAttribution=)]
    2020-07-13 drwjr
  3. [GetPortalCommentsPageByObjectIdResponse(id=1823613, encodeId=a56b182361365, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Thu Jan 14 16:17:00 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008137, encodeId=8dbb200813e86, content=<a href='/topic/show?id=f244465139' target=_blank style='color:#2F92EE;'>#CHINA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4651, encryptionId=f244465139, topicName=CHINA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Mon Jul 13 09:17:00 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404123, encodeId=7ae8140412346, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Mar 05 00:17:00 CST 2020, time=2020-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027316, encodeId=ac10102e316ac, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Mar 03 12:17:00 CST 2020, time=2020-03-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1823613, encodeId=a56b182361365, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Thu Jan 14 16:17:00 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008137, encodeId=8dbb200813e86, content=<a href='/topic/show?id=f244465139' target=_blank style='color:#2F92EE;'>#CHINA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4651, encryptionId=f244465139, topicName=CHINA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Mon Jul 13 09:17:00 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404123, encodeId=7ae8140412346, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Mar 05 00:17:00 CST 2020, time=2020-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027316, encodeId=ac10102e316ac, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Mar 03 12:17:00 CST 2020, time=2020-03-03, status=1, ipAttribution=)]
    2020-03-03 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

Schizophr Res:精神分裂症共病肥胖与认知功能损伤呈负相关

肥胖是精神分裂症中一种典型的代谢综合征,荟萃分析报告了精神分裂症合并肥胖的风险升高,肥胖发病率是一般人群的1.5-4倍。

Lancet:32种常见抗精神分裂药物的疗效及不良事件差异研究

32种常见口服抗精神病药物之间有一定的疗效差异,副作用的差异更为明显

JAMA Psychiatry:氯氮平一线治疗抗药性精神分裂症

氯氮平是抗药性精神分裂症患者的首先治疗手段

无需吃药!FDA批准**精神分裂症皮肤给药疗法

今日,久光制药(Hisamitsu Pharmaceutical)旗下的Noven Pharmaceuticals公司宣布,美国FDA批准其透皮给药系统Secuado(asenapine)上市,用于治疗精神分裂症成人患者。Secuado是目前首款,也是唯一一款用于治疗精神分裂症患者的透皮贴剂(transdermal patch)疗法。

2019 BAP循证指南:精神分裂症的药物治疗(更新版)

2019年12月,英国精神药理协会(BAP)发布了精神分裂症的药物治疗指南,该指南是对2011年版指南的更新,专家组讨论了精神分裂症药物治疗的目标和范围。指南涵盖了精神分裂症各个阶段的药物治疗,包括首发、复发和对标准治疗方法无效的疾病。

PureTech的新型口服制剂KarXT在治疗精神分裂症的II期临床中展现前景

PureTech宣布了其毒蕈碱受体激动剂xanomeline的口服制剂KarXT 在II期试验治疗精神分裂症患者的急性精神疾病的积极结果。与安慰剂相比,KarXT在阳性和阴性综合症状量表(PANSS)总分中显示出统计学上显着且具有临床意义的平均降低。该药物还显示出良好的总体耐受性,并且还观察到PANSS阳性和PANSS阴性评分的次要终点在统计学上显着降低。